Halofantrine causes significant dose-dependent QTc prolongation and AV block in vivo in guinea-pigs, highlighting the utility of in vivo models over in vitro preparations for studying its cardiotoxicity.
No takes yet. Share an insight, caveat, or question.
Animal data should not yet alter halofantrine use; supports prioritizing in vivo models for cardiotoxicity screening.
Batey et al. (1997) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: